Margaret Tooth Sells 978 Shares of Trupanion (NASDAQ:TRUP) Stock

Trupanion, Inc. (NASDAQ:TRUP) CEO Margaret Tooth sold 978 shares of the business’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total value of $28,410.90. Following the completion of the sale, the chief executive officer owned 175,401 shares in the company, valued at approximately $5,095,399.05. This trade represents a 0.55% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Margaret Tooth also recently made the following trade(s):

• On Monday, May 25th, Margaret Tooth sold 491 shares of Trupanion stock. The stock was sold at an average price of $21.86, for a total value of $10,733.26.

Trupanion Stock Up 2.2%

Trupanion stock traded up $0.68 during midday trading on Thursday, reaching $31.00. The stock had a trading volume of 541,432 shares, compared to its average volume of 440,807. The stock has a market capitalization of $1.36 billion, a P/E ratio of 58.49, a price-to-earnings-growth ratio of 2.23 and a beta of 1.39. The firm’s fifty day simple moving average is $25.20 and its 200-day simple moving average is $26.09. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.77 and a current ratio of 1.77. Trupanion, Inc. has a 1-year low of $21.16 and a 1-year high of $50.06.

Trupanion (NASDAQ:TRUP) last released its quarterly earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a return on equity of 5.96% and a net margin of 1.53%.The firm had revenue of $392.93 million during the quarter, compared to the consensus estimate of $389.72 million. During the same quarter in the prior year, the firm posted $0.22 EPS. The business’s revenue was up 11.1% on a year-over-year basis. As a group, analysts expect that Trupanion, Inc. will post 0.58 EPS for the current fiscal year.

Hedge Funds Weigh In On Trupanion

A number of institutional investors have recently bought and sold shares of TRUP. Dimensional Fund Advisors LP lifted its position in Trupanion by 15.7% during the first quarter. Dimensional Fund Advisors LP now owns 702,086 shares of the financial services provider’s stock worth $17,981,000 after acquiring an additional 95,064 shares during the last quarter. Polar Capital Holdings Plc lifted its holdings in Trupanion by 13.5% during the 4th quarter. Polar Capital Holdings Plc now owns 1,475,000 shares of the financial services provider’s stock worth $55,121,000 after purchasing an additional 175,000 shares during the last quarter. Kopion Asset Management LLC lifted its holdings in Trupanion by 30.9% during the 2nd quarter. Kopion Asset Management LLC now owns 522,999 shares of the financial services provider’s stock worth $12,955,000 after purchasing an additional 123,308 shares during the last quarter. Hosking Partners LLP boosted its stake in Trupanion by 8.1% in the 4th quarter. Hosking Partners LLP now owns 465,950 shares of the financial services provider’s stock valued at $17,413,000 after purchasing an additional 35,020 shares during the period. Finally, R Squared Ltd boosted its stake in Trupanion by 44.7% in the 4th quarter. R Squared Ltd now owns 9,075 shares of the financial services provider’s stock valued at $339,000 after purchasing an additional 2,803 shares during the period.

Wall Street Analysts Forecast Growth

A number of research firms have recently commented on TRUP. Stifel Nicolaus set a $28.00 price objective on shares of Trupanion in a research note on Friday, June 26th. Zacks Research upgraded Trupanion from a “hold” rating to a “strong-buy” rating in a report on Friday, July 24th. Weiss Ratings raised Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday. Finally, Atlantic Securities set a $42.00 price target on Trupanion in a research note on Wednesday, July 15th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $41.60.

About Trupanion

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.